Ignite Creation Date:
2025-12-24 @ 9:33 PM
Ignite Modification Date:
2026-03-29 @ 1:19 PM
Study NCT ID:
NCT01198132
Status:
COMPLETED
Last Update Posted:
2017-12-14
First Post:
2010-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
701068-524
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |